Cipla inks pact with Teva to market its products

Cipla has joined hands with Teva Pharmaceuticals for sales and distribution of its drugs in South Africa


The collaboration will focus on oncology, women health's products etc

Indian Pharma giant Cipla has entered into an agreement with Israel-based Teva Pharmaceuticlas. As per the agreement, Cipla Medpro will exclusively market Teva's pharmaceutical products portfolio in South Africa.

Mr Subhanu Saxena, managing director and global CEO, Cipla said, "Cipla believes that the collaboration with Teva reaffirms its commitment of advancing healthcare to all South Africans" in a statement.

The collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology, and other speciality products.



Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email